ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 142 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 4.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $560,000 | -25.8% | 54,615 | +7.6% | 0.00% | -20.0% |
| Q3 2018 | $755,000 | -3.9% | 50,775 | +2.1% | 0.01% | 0.0% |
| Q2 2018 | $786,000 | +25.4% | 49,754 | +0.8% | 0.01% | +25.0% |
| Q1 2018 | $627,000 | -7.7% | 49,351 | -16.8% | 0.00% | -20.0% |
| Q4 2017 | $679,000 | -22.9% | 59,340 | -17.5% | 0.01% | -28.6% |
| Q3 2017 | $881,000 | +175.3% | 71,932 | +157.5% | 0.01% | +133.3% |
| Q2 2017 | $320,000 | -16.7% | 27,936 | +51.5% | 0.00% | 0.0% |
| Q1 2017 | $384,000 | +7.9% | 18,441 | +7.9% | 0.00% | 0.0% |
| Q4 2016 | $356,000 | -28.8% | 17,092 | +12.1% | 0.00% | -25.0% |
| Q3 2016 | $500,000 | +24.4% | 15,251 | -3.0% | 0.00% | 0.0% |
| Q2 2016 | $402,000 | – | 15,730 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
| Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
| PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
| Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
| Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
| PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
| Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
| Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |